Arkolith/Insider Trading/SUPN/Form 4

Hudson Frederick M.

DirectorSUPERNUS PHARMACEUTICALS, INC. (SUPN) · full profile →Form 4 · filed Mar 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$272K
Net Open-Market Flow
-$272K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2026Sell(S)5K$50.61$272K60K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001438462-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML